views
![Digital Biomarkers Market Growth Accelerated by Adoption of Digital Biomarkers in Healthcare](https://s3.us-west-2.amazonaws.com/timessquarereporter.com/upload/media/posts/2024-01/31/digital-biomarkers-market-growth-accelerated-by-adoption-of-digital-biomarkers-in-healthcare_1706702864-b.jpg)
Digital biomarkers incorporate technology and tools to digitally measure human physiological signals and behavior for clinical or medical purposes. Digital biomarkers can offer highly objective and quantifiable data compared to traditional subjective assessments.
The global Digital Biomarkers Market is estimated to be valued at US$ 3.3 billion in 2024 and is expected to exhibit a CAGR of 8.0% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The adoption of digital biomarkers is increasing exponentially driven by the growing need for precision medicine and remote patient monitoring. Digital biomarkers offer continuous and objective monitoring of patients without physical visits to clinics or hospitals. This allows early detection of therapeutic response as well as monitoring of disease progression. Various technology companies and digital health platforms are integrating digital biomarkers within their applications and services to offer cost-effective solutions to pharmaceutical and biotechnology companies for clinical trials and drug development. The continuous growth in acceptance of digital healthcare tools among patients and physicians is expected to drive significant growth of the digital biomarkers market during the forecast period.
Segment Analysis:
The global digital biomarkers market can be segmented on the basis of the type of data collected, deployment model, therapeutic areas and application. Based on the data collected, the physiological segment dominated the market in 2021 as these digital biomarkers help assess heart rate variability, physical activity, and sleep patterns. Based on deployment, digital biomarkers deployed on mobile apps dominated the market owing to the high adoption of smartphones and user-friendliness of apps. Based on therapeutic areas, the neurological disorders segment accounted for the largest share due to rising prevalence of chronic neurological conditions globally. On the basis of applications, the schizophrenia segment holds the highest market share due to growing need for improved treatment through digitalization.
Key Takeaways:
The global digital biomarkers market is expected to witness high growth during the forecast period. Global Digital Biomarkers Market Size is estimated to be valued at US$ 3.3 billion in 2024 and is expected to exhibit a CAGR of 8.0% over the forecast period 2024 to 2031.
- Regional analysis: The North America region currently dominates the global digital biomarkers market and is expected to continue its dominance during the forecast period. This is attributed to rising investments for research & development activities of digital biomarkers by pharmaceutical and technology companies in the US and Canada.
- Key players: Key players operating in the Digital Biomarkers market are Purina Mills LLC, Nutreco N.V., Roquette Freres S.A. , Evonik Industries A G, Charoen Pokphand Foods PLC, Alltech Inc., Associated British Foods Plc., Koninklijke DSM NV, BASF SE, ACI Godrej Agrovet Private Limited.
- Key players related content: Key players operating in the digital biomarkers market are focusing on product launches and partnerships with digital health companies to expand their geographic presence. For instance, in 2021, Purina Mills LLC launched a new digital pet health platform in partnership with Anthropic to develop AI-powered digital biomarkers.
Get More Insights on this topic- https://www.marketwebjournal.com/digital-biomarkers-market-forecast-overview-and-outlook/
![disclaimer](https://www.timessquarereporter.com/disclaimer-timessquarereporter.jpg)
Comments
0 comment